//
GHRH/GHRP combination for synergistic growth hormone research
These products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
This blend combines CJC-1295 (a GHRH analogue) with Ipamorelin (a ghrelin receptor agonist) in a single vial. Research into the combination leverages their complementary mechanisms — pituitary GHRH receptor activation alongside ghrelin receptor stimulation — to study synergistic growth hormone axis modulation.
Combination GH secretagogue research with CJC-1295 and Ipamorelin has characterized their synergistic amplification of GH pulse amplitude, with studies noting that GHRH and GHRP co-administration produces GH release exceeding either compound alone.
Price comparison based on publicly available data. Competitor prices may vary.
Store in refrigerator at 4°C, tightly sealed, away from heat, light and moisture.. Keep frozen until ready to reconstitute.
Use sterile water for injection. Allow to reach room temperature before reconstitution.
Stable for 24 months when stored properly. Once reconstituted, use within 30 days.